Mieloma multiplo: i bisogni concreti di pazienti e caregiver

Alongside therapeutic advances in multiple myeloma, the daily needs of patients and caregivers are becoming increasingly pressing. How do you navigate a long and complex treatment journey away from home? What psychological, logistical, and healthcare support is needed? And how can organizations help make the disease experience more sustainable? In a context of growing innovation, the issue of comprehensive care remains central to ensuring equity and quality of care. We discussed this with Matilde Cani, Head of Institutional Projects at AIL - Italian Association against Leukemia, Lymphoma, and Myeloma, Milan Monza Brianza, whom we met at the event dedicated to new CAR-T therapies in multiple myeloma.

Multiple myeloma: a new quadruplet therapy that reduces relapses has been approved in Italy.
▶︎

Multiple myeloma: a new quadruplet therapy that reduces relapses has been approved in Italy.

Multiple myeloma: innovative approaches in the early stages of the disease
▶︎

Multiple myeloma: innovative approaches in the early stages of the disease

She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎

She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳

Multiple Myeloma: What's the Progress? | Dr. Claudio Cerchione
▶︎

Multiple Myeloma: What's the Progress? | Dr. Claudio Cerchione

LUPUS TODAY AND TOMORROW - Presentation by Rosa Pelissero - Introduction by Marta Mosca
▶︎

LUPUS TODAY AND TOMORROW - Presentation by Rosa Pelissero - Introduction by Marta Mosca

MIELOMA MULTIPLO: CONTENIMENTO DELLA MALATTIA E REMISSIONE PERMANENTE LE PAROLE CHIAVE
▶︎

MIELOMA MULTIPLO: CONTENIMENTO DELLA MALATTIA E REMISSIONE PERMANENTE LE PAROLE CHIAVE

Innovation in multiple myeloma: why information and support remain crucial
▶︎

Innovation in multiple myeloma: why information and support remain crucial

Multiple myeloma: how and why should minimal residual disease be assessed?
▶︎

Multiple myeloma: how and why should minimal residual disease be assessed?

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

Mieloma multiplo: oggi la guarigione funzionale è un obiettivo più vicino | Dott. Giuseppe Mele
▶︎

Mieloma multiplo: oggi la guarigione funzionale è un obiettivo più vicino | Dott. Giuseppe Mele

Mieloma multiplo, come ottimizzare la profilassi infettiva e gestire le tossicità a lungo termine?
▶︎

Mieloma multiplo, come ottimizzare la profilassi infettiva e gestire le tossicità a lungo termine?

Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor
▶︎

Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor

Polycythemia vera – Management of this rare blood cancer
▶︎

Polycythemia vera – Management of this rare blood cancer

La Gammopatia Monoclonale si trasforma sempre in Mieloma Multiplo?
▶︎

La Gammopatia Monoclonale si trasforma sempre in Mieloma Multiplo?

STAGE 4 Cancer After MONTHS of Itching! - Amanda | Stage 4 Hodgkin Lymphoma | The Patient Story
▶︎

STAGE 4 Cancer After MONTHS of Itching! - Amanda | Stage 4 Hodgkin Lymphoma | The Patient Story

Multiple myeloma: can it be considered a chronic disease today?
▶︎

Multiple myeloma: can it be considered a chronic disease today?

The Complete Cardiology Masterclass: Exam-Ready in One Video
▶︎

The Complete Cardiology Masterclass: Exam-Ready in One Video

The Most Requested Haircut for Women Over 70 | She Drove All the Way From Idaho for This Haircut! ✨
▶︎

The Most Requested Haircut for Women Over 70 | She Drove All the Way From Idaho for This Haircut! ✨

Mieloma Multiplo sopravvivenza aumentata grazie alle nuove cure
▶︎

Mieloma Multiplo sopravvivenza aumentata grazie alle nuove cure

Phenylketonuria, why early diagnosis and therapeutic alliance change the future
▶︎

Phenylketonuria, why early diagnosis and therapeutic alliance change the future